Comprehensive Pharmacology Study Guide on Antidepressants and Antipsychotic Drugs
Pathophysiology and General Concepts of Depression
Neurotransmitter Alterations in Depression:
- Depression is characterized by decreased synaptic concentrations of monoamine neurotransmitters.
- The primary neurotransmitters with reduced levels in depression are noradrenaline () and serotonin ().
Monoamine Reuptake Inhibition:
- Agents that inhibit the reuptake of both serotonin () and noradrenaline () into presynaptic nerve terminals are classified primarily as Tricyclic Antidepressants (TCAs).
Tricyclic Antidepressants (TCAs)
Pharmacological Properties and Receptor Profile:
- In addition to inhibiting the reuptake of and , TCAs possess prominent secondary receptor-blocking properties.
- TCAs exhibit significant anticholinergic activity (muscarinic receptor blockade).
- TCAs exhibit significant -adrenergic receptor-blocking properties (-blockade).
- TCAs also exhibit anti-histaminic () blocking properties.
Chemical Classification of Tricyclic Antidepressants:
- Dibenzoazepine Derivatives:
- Representative agents include Imipramine and Desipramine.
- Therapeutic dosing range: .
- Dibenzocycloheptene Derivatives:
- Representative agents include Amitryptyline and Nortryptyline.
- Dibenzoxazepine Derivatives:
- Representative agent: Amoxapine.
Adverse Effects of TCAs:
- Weight gain.
- Hypotension (orthostatic/postural hypotension secondary to -adrenergic blockade).
- Reflex tachycardia (resulting from peripheral vasodilation and anticholinergic vagolytic effects).
Specific Therapeutic Applications of TCAs:
- Enuresis (Bedwetting): Nocturnal bedwetting in children is controlled using a low dose of Imipramine ().
Selective Serotonin Reuptake Inhibitors (SSRIs)
Drug Class Overview:
- SSRIs selectively inhibit the reuptake of serotonin () into the presynaptic neuron without significantly affecting noradrenaline reuptake.
- Individual drugs within this class:
- Fluoxetine
- Fluvoxamine
- Sertaline
- Citalopram
- Paroxetine
Receptor Selectivity and Tolerability:
- SSRIs feature minimum anticholinergic activity.
- SSRIs feature minimum -blocking activity.
- SSRIs feature minimum anti-histamine receptor-blocking activity.
- This reduced off-target affinity results in an improved side-effect profile compared to classic TCAs.
Indications:
- Drug of Choice (DOC) for Obsessive-Compulsive Disorder (O.C.D.): SSRIs (e.g., Fluoxetine, Paroxetine, etc.).
Monoamine Oxidase Inhibitors (MAOIs) and the Cheese Reaction
Classification of MAO Inhibitors:
- Selective MAO-A Inhibitors:
- Moclobemide
- Clorgyline
- Non-selective MAO Inhibitors:
- Isocarboxazide
- Phenelzine
- Tranylcypromine
The Cheese Reaction:
- Precipitating Agents: Likely occurs following the ingestion of tyramine-rich foods (such as aged cheese) during treatment with MAO inhibitors.
- Clinical Presentation: Manifests as severe, acute hypertension (hypertensive crisis) due to the failure to metabolize exogenous tyramine, causing systemic catecholamine release.
- Treatment Protocol: The severe hypertension in cheese reactions is treated pharmacologically with:
- Phentolamine (an -adrenergic antagonist)
- Labetolol (a mixed /-adrenergic antagonist)
Atypical and Other Specific Antidepressants
Selective Noradrenaline Reuptake Inhibitors (Selective NRIs):
- Specific agents include Nisoxetine and Reboxetine.
Serotonin-Modulating Antidepressants:
- Trazodone: Notable for causing priapism (prolonged, painful penile erection) as a specific adverse drug reaction.
Presynaptic -Adrenoceptor Antagonists:
- Presynaptic blockade acts to enhance monoaminergic transmission in depression.
- Representative agents include Mainserin and Mirtazapine.
- Mainserin: Notable adverse effect is bone marrow depression (agranulocytosis/aplastic anemia).
- Mirtazapine Mechanism of Action:
- Blocks presynaptic -adrenergic auto- and hetero-receptors.
- Concurrently blocks serotonergic and receptors.
Bupropion:
- Exhibits distinct central nervous system amphetamine-like excitatory properties.
- Indicated for clinical use in smoking cessation regimens.
Pathophysiology and Terminology of Psychosis
General Terminology:
- Antipsychotics are also designated clinically as neuroleptics or major tranquilizers.
Neurochemical Basis of Psychosis:
- Psychosis is associated with an increased level of dopamine (), specifically concentrated within the mesolimbic area of the brain.
Psychiatric Symptoms:
- Hallucination: Defined as a sensory perception of something that does not exist in the external environment.
- Delusion: Defined as a false personal belief that is firmly sustained and resistant to confrontation with actual facts or contrary evidence.
Classification and Mechanisms of Antipsychotic Drugs
Typical Antipsychotics:
- First-generation agents that primarily block dopamine receptors in the central nervous system.
Atypical Antipsychotics:
- Second-generation agents that block both dopamine receptors and serotonin receptors (dual receptor blockade).
Chemical Derivatives of Phenothiazine Antipsychotics
Propylamino Phenothiazine Derivatives (Aliphatic Side Chain):
- Promazine
- CPZ (Chlorpromazine)
- Triflupromazine
Piperidine Phenothiazine Derivatives:
- Thioridazine
- Mesoridazine
Propylpiperazine Derivatives (Piperazine Phenothiazines):
- Prochlorperazine
- Triflupromazine
- Perphenazine